Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ophthalmology Community Focuses on Laser Cataract Technology

Executive Summary

Among new technologies discussed at three major ophthalmology conferences this fall, it was the emerging field of laser cataract surgery that generated the greatest interest among attendees, although the first system is just now being launched commercially and there are many unanswered questions regarding the economics of this promising technology and how it will be adopted.

You may also be interested in...



Laser Cataract Surgery: Sorting Out The Business Case

The once staid US cataract surgery market has evolved considerably over the past several years. A trio of conferences this fall provided updates on the latest developments.

Avedro Financing Highlights New Ophthalmology Market

In early July, ophthalmology start-up Avedro closed a $25 million Series C round. In a refractive surgery market where, apart from laser cataract surgery, there hasn't been much new to speak of in years, Avedro has a potentially disruptive technology, although the company plans not to disrupt as much as to grow the market.

Avedro Financing Highlights New Ophthalmology Market

In early July, ophthalmology start-up Avedro closed a $25 million Series C round. In a refractive surgery market where, apart from laser cataract surgery, there hasn't been much new to speak of in years, Avedro has a potentially disruptive technology, although the company plans not to disrupt as much as to grow the market.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL1121650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel